Rare diseases
Investigational molecules
Locations
Back to Germany17 clinical trials in Reutlingen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Multiple trials focusing on gastroesophageal cancer and colorectal cancer treatments, evaluating innovative combination therapies and surgical approaches.
Research includes novel antibody combinations and targeted therapies for improved patient outcomes.
Innovative studies examining treatments for HER2-negative breast cancer and triple-negative breast cancer, with focus on immunotherapy approaches.
Trials aim to improve survival rates through personalized treatment approaches.
Studies investigating new treatments for follicular lymphoma and aggressive B-cell lymphomas, particularly in older patients.
Focus on developing less toxic yet effective treatment options.
Research targeting rare and specific cancers including cholangiocarcinoma and FGFR-altered tumors.
Emphasis on precision medicine and personalized treatment strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
